Brooklyn, New York, June 06, 2022 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Life Science Consumables Market is projected to grow at a CAGR of 11.4% from 2022 to 2027.
The rising popularity of personalized therapies, declining sequencing prices, and improved genomic data management algorithm and solutions are some of the key factors that are driving the market revenue.
Browse 153 Market Data Tables and 112 Figures spread through 187 Pages and in-depth TOC on “Global Life Science Consumables Market - Forecast to 2027’’
Key Market Insights
- As per the application outlook, the cell biology segment is expected to be the highest revenue-generating segment in the 2021 life science consumables market
- Based on the technology outlook, the PCR & qPCR segment is estimated to dominate the 2021 global market in terms of revenue generation
- Among the end-users, government and academic research institutes are estimated to capture the maximum revenue share in the 2021 market
- North America (the United States, Canada, and Mexico) market is estimated to account for a major revenue share in the global life science consumables market from 2022 to 2027
- The Asia Pacific region is expected to serve as the fastest revenue-generating market during the forecast period
- Thermofisher Scientific, Inc., Merck KGaA, LONZA, Becton, Dickinson and Company, Takara Bio Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, Bio-Rad Laboratories Inc., Miltenyi Biotec, and Danaher Corporation among others, are some of the key players in the life science consumables market
Request a Sample Copy of the report @ https://www.globalmarketestimates.com/market-report/life-science-consumables-market-3829
Technology Outlook (Revenue, USD Billion, 2022-2027)
- PCR & qPCR
- Sequencing Technology
- Flow Cytometry
- Microarray
- Mass Spectrometry
- Chromatography
- Other Technologies
Application Outlook (Revenue, USD Billion, 2022-2027)
- Proteomics
- Genomics
- Cell Biology
- Others
End-use Outlook (Revenue, USD Billion, 2022-2027)
- Pharmaceutical & Biotechnology Company
- Government and Academic Research Institutes
- Others
Regional Outlook (Revenue, USD Billion, 2022-2027)
North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
Central & South America
- Brazil
- Rest of CSA
Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
